Upcoming Meeting of the Novel and Exceptional Technology and Research Advisory Committee

On December 3, 2024, NIH will be hosting a virtual meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC).  At this meeting, the committee will receive an update from the Working Group on Engaging the Public as Partners in Clinical Research (ENGAGE) and discuss the next steps regarding its current charge.

A draft agenda and webcast information, can be found on the meeting page of the OSP Website.

Questions may be sent to [email protected].

If you are not yet a subscriber to this listserv, please sign up here.  Also, please consider following us on X @NIH_OSP  and LinkedIn

On the Road: Idaho Falls Edition

I’m writing this blog on my way home from Idaho Falls, Idaho, tremendously excited to share with you all the progress being made to engage communities in clinical research. Through NIH’s new ENGAGE initiative, OSP and the NExTRAC are working to create an NIH-wide framework for including public voices in the planning, design, and conduct of clinical research. As part of this effort, OSP is hosting 12 “community conversations” around the country to learn more from individuals, families, and communities about how they think about clinical research – what it is, who is involved, and what it means (or doesn’t mean) to people in their everyday lives.

For the Idaho Falls conversation, folks spent the evening sharing their perspectives on a range of topics, including reflecting on the different types of clinical research studies, the clinical research lifecycle, and how they saw themselves and their communities benefiting from research. We also spent a lot of time digging into how clinical research priorities and study goals are set. It was clear that communities feel that they possess a unique vantage point that should help drive priority setting, which makes sense given that where you live is potentially the biggest driver of your health. Questions about returning “value” from the research conducted in communities was also on the forefront of people’s minds.

I am extremely grateful that people were eager to be candid, expressing a wide range of opinions. Issues sparking conversation ranged from politicization of empirical data, evolving trust in science, importance of mitigating inherent biases, and how to ensure representation and inclusiveness. While individual perspectives varied, there were clear threads of commonalities weaving throughout the conversation, including a genuine interest to find ways to sustain trustworthy relationships with researchers and the government so that we can collectively improve health outcomes for all.

By the end of the evening, folks were cautiously excited: how will NIH turn what we are saying into something with impact? When will we see results? The good news is that OSP has been largely learning from the NIH and Centers who have been doing this for some time. Additionally, if you’ve heard NIH Director, Monica Bertagnolli, you know that meeting patients where they are is one of her top priorities. Just this year, NIH launched the CARE for Health Initiative which works with communities to define the research questions that matter most to them by working with primary care clinics. By embedding these conversations in communities, we can work together to establish a foundation for sustained engagement with communities that are underrepresented in clinical research.

Finally, as I write this post, I am reflecting on how grateful I am to all the Idaho Falls folks (Idahoans, as I learned 😊) who came out to share their stories with us. We are learning so much from communities across the country and I encourage readers to keep tabs on our progress by checking out https://partnersinresearch.nih.gov/community-conversations/. Learning from people with different experiences, perspectives, and circumstances is what policy-making is all about and is necessary for making scientific research, and its outputs, most meaningful and impactful for all.

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

(Coming Soon) Supervisory Health Science Policy Analyst (Assistant Director for Biosecurity)

The NIH Office of Science Policy seeks an innovative leader to serve as the Assistant Director for Biosecurity within its Division of Biosafety, Biosecurity, and Emerging Biotechnologies.  The ideal candidate will have extensive experience and knowledge regarding relevant scientific and policy issues such as those related to biosecurity, dual use research, preparedness, synthetic biology, and the bioeconomy.

The position is being advertised as a supervisory GS-14.  The application period will open on Thursday, October 17 and close on Monday October 21, 2024.

Current federal employees may apply at: https://www.usajobs.gov/job/812289700

Members of the public should apply at: https://www.usajobs.gov/job/812289500

For more information about the NIH Office of Science Policy, go to https://osp.od.nih.gov/

NIH Issues New Centralized Resource of Policies and Practices for Promoting Responsible Use of Artificial Intelligence

OSP has issued a new resource to assist the research community in understanding how NIH policies guide artificial intelligence (AI)-related research.  The purpose of the resource is to illustrate the applicability of existing policies and guidance to research involving AI technologies. The resource can be accessed at: https://osp.od.nih.gov/policies/artificial-intelligence/.

To gain further perspective how NIH is approaching AI-related research, please see the latest Under the Poliscope blog from NIH Associate Director for Science Policy, Dr. Lyric Jorgenson.

Questions on the resource may be sent to [email protected]

If you are not yet a subscriber to this listserv, please sign up here.  Also, please consider following us on X @NIH_OSP  and LinkedIn